In the current study, we observed treatment with triptolide significantly attenuated cardiac inflammation and fibrosis through suppressing the activity and the expression of NF-κB in a rat model of diabetic cardiomyopathy. Here, NFKB1 is linked to diabetic cardiomyopathy.